NOT KNOWN FACTUAL STATEMENTS ABOUT PRIMOBOLAN

There were documented serious instances of peliosis hepatis, occasionally connected with liver failure and intra-abdominal hemorrhage; liver tumors, sometimes lethal; and blood lipid alterations connected with enhanced danger of atherosclerosis led FDA to remove acceptance in June 2023. Further warnings involve the challenges related to cholestatic